Lisa Harding is a leading voice in interventional psychiatry with extensive experience treating treatment-resistant depression (TRD) using advanced modalities including IV ketamine, esketamine (Spravato™), and transcranial magnetic stimulation (TMS). As a board-certified psychiatrist and the founder of a thriving private practice dedicated to TRD, she offers invaluable insights into both clinical outcomes and the practical implementation of interventional treatments in a private practice setting. Having addressed audiences nationally and worldwide, including in Saudi Arabia, Singapore, Australia, Italy, Romania, Brazil, Mexico, Guyana, and St. Lucia. She has held leadership roles in the American Psychiatric Association (APA) and served as Vice President of the American Society of Ketamine Physicians, Psychotherapists & Practitioners she is ideal for a global perspective on clinical care.